Montag, 04.05.2026, Calendar Week 19, 124. day of the year, 241 days remaining until EoY.

Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.

Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

FR0000121667

Filter zurücksetzen

Do you already know our new terminal view? Click here.

FIGI: BBG000BBN5Y8

EssilorLuxottica SA

GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $TF-76

NAME

EssilorLuxottica SA

ISIN

FR0000121667

TICKER

MIC

XPAR

REUTERS

ESLX.PA

BLOOMBERG

EL FP

So., 03.05.2026 Essilor Luxottica

Newsfeed

XFRA: CAPITAL ADJUSTMENT INFORMATION - 05.05.2026 - FR0000121667 | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica acquires a stake in Top Charoen, reinforcing its presence in Thailand | EssilorLuxottica SA

EssilorLuxottica and Meta Expand AI Glasses Portfolio with Ray-Ban Meta Optics Styles | EssilorLuxottica SA

EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050 | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 11, 2026 | EssilorLuxottica SA

Belice avanza en la salud ocular nacional con el lanzamiento de la iniciativa SPECS 2030 de la OMS | EssilorLuxottica SA

Belize Advances National Eye Health with Launch of WHO SPECS 2030 Initiative | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2026 | EssilorLuxottica SA

EssilorLuxottica: 2025 Universal Registration Document filed | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica: Disclosure of transactions in own shares | EssilorLuxottica SA

EssilorLuxottica announces the launch of a share buyback program | EssilorLuxottica SA

EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors | EssilorLuxottica SA

EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026 | EssilorLuxottica SA

EssilorLuxottica: Full-Year 2025 Results Conference Call Invitation | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025 | EssilorLuxottica SA

EssilorLuxottica and Burberry announce licensing partnership renewal | EssilorLuxottica SA

EssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprint | EssilorLuxottica SA

EssilorLuxottica joins forces with Fondazione Chips-IT to accelerate the future of smart eyewear | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2025 | EssilorLuxottica SA

EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2025 | EssilorLuxottica SA

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution | EssilorLuxottica SA

Roger Federer Foundation Partners with OneSight EssilorLuxottica Foundation to Bring Vision Care to Thousands of Zambian Schoolchildren | EssilorLuxottica SA

EssilorLuxottica: Q3/9M 2025 Revenue - Revenue up 11.7% in the third quarter, best quarterly performance ever for the Group | EssilorLuxottica SA

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 | EssilorLuxottica SA

EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation | EssilorLuxottica SA

EssilorLuxottica completes acquisition of Optegra | EssilorLuxottica SA

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States | EssilorLuxottica SA

EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025 | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2025 | EssilorLuxottica SA

Public and Private Sectors Unite to Enhance Vision Care Access for Patients in Need Ahead of SG60 | EssilorLuxottica SA

EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing | EssilorLuxottica SA

EssilorLuxottica: Publication of the 2025 Interim Financial Report | EssilorLuxottica SA

EssilorLuxottica: Q2/H1 2025 Results - Sound revenue growth at 7.3% in Q2 and H1, AI glasses speeding up further | EssilorLuxottica SA

EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials | EssilorLuxottica SA

EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation | EssilorLuxottica SA

The OneSight EssilorLuxottica Foundation Sets New Pace in Africa with One Million People Reached in Six Months of 2025 | EssilorLuxottica SA

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025 | EssilorLuxottica SA

EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of Performance AI glasses for athletes and fans alike | EssilorLuxottica SA